logo

For the Inventor, By the Inventor

Bogis-Bossey, Switzerland

Craig Leigh Bentzen

This inventor holds 15 USPTO granted patents. Top assignees: Symphar S.a., Ilex Products, Inc., Ilex Oncology Research S.a.. Active years: 1982-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig Leigh Bentzen. Retrieved from https://idiyas.com/inventor/craig-leigh-bentzen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 80.0

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 102(Granted Patents)


Location History:

  • Onex, CH (1982 - 1983)
  • Chavannes de Bogis, CH (1983 - 1987)
  • Bogis-Boseey, CH (2000)
  • Geneva, CH (2000 - 2003)
  • Bogis-Dossey, CH (2005)
  • Bogis-Bossey, CH (1991 - 2007)

Company Filing History:

goldMedal10 out of 12 
 
Symphar S.a.
 patents
silverMedal3 out of 6 
 
Ilex Products, Inc.
 patents
bronzeMedal1 out of 1 
 
Ilex Oncology Research S.a.
 patent
4. 1 out of 2,198 
 
Smithkline Beecham Corporation
 patents
5. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1982-2007

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7208481 - Aminodiphosphonate apolipoprotein E modulators (2007-04-24),
2. 6872711 - β-substituted β-aminoethyl phosphonate derivatives (2005-03-29),
3. 6706698 - &agr;-Substituted &bgr;-aminoethyl phosphonate derivatives (2004-03-16),
4. 6660724 - Compounds and pharmaceutical compositions containing them (2003-12-09),
5. 6303784 - Pharmaceutical aminophosphonic acid derivatives (2001-10-16),
6. 6127350 - Use of phenol substituted diphosphonates as antineoplastic agents (2000-10-03),
7. 6060464 - Compounds and pharmaceutical compositions containing them (2000-05-09),
8. 5424303 - Substituted aminophosphonate derivatives, process for their preparation (1995-06-13),
9. 5128331 - Method for lowering plasma lipid levels or blood pressure (1992-07-07),
10. 5043330 - Phenol substituted gem-diphosphonate derivatives, process for their (1991-08-27),
11. 4696920 - Certain 2-substituted 1,3-propylidenediphosphonate derivatives, (1987-09-29),
12. 4416877 - Anti-atherosclerotic pharmaceutical compositions containing (1983-11-22),
13. 4371527 - Therapeutic process with diphosphonate compounds (1983-02-01),
14. 4309364 - Diphosphonates (1982-01-05),
15. 4309188 - Method for the clinical separation of .alpha.- and .beta.-lipoproteins (1982-01-05),

Title: The Innovative Contributions of Craig Leigh Bentzen

Introduction

Craig Leigh Bentzen is a notable inventor based in Bogis-Bossey, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of apolipoprotein E levels. With a total of 15 patents to his name, Bentzen's work has implications for various therapeutic applications.

Latest Patents

Among his latest patents, Bentzen has developed aminodiphosphonate apolipoprotein E modulators. This invention relates to methods of using aminodiphosphonate to modulate apolipoprotein E levels, which can be beneficial in treating cardiovascular and neurological diseases. Another significant patent involves β-substituted β-aminoethyl phosphonate derivatives. This invention focuses on novel derivatives that can lower plasma levels of apo (a), Lp(a), apo B, and associated lipoproteins, as well as total cholesterol levels.

Career Highlights

Throughout his career, Craig Leigh Bentzen has worked with various companies, including Symphar S.A. and Ilex Products, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Bentzen has collaborated with notable individuals in his field, including Eric Joseph Niesor and Hieu Trung Phan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Craig Leigh Bentzen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…